Terumo Corporation · TSE:4543
Terumo — Investor Presentation (December 2016)
11 slides from Terumo's investor presentation, Dec 12, 2016
Slide 1: Blood Management Company
5 Blood David Perez President Management Blood Management Company Company © Terumo Corporation
Slide 2: History of Long-Term Profitable Growth
History of Long-Term Profitable Growth Annual Blood Management Company Sales Industry Return to Growth Rapid Global Stable Growth Consolidation and in Existing and Market Expansion Transformation New Markets 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 20
Slide 3: New Clinical Horizons
NEW CLINICAL HORIZONS Shifting our Focus from Products to Disease-States and Medical Specialties ONCOLOGY AUTOIMMUNE DISORDERS Product Disease HEMATOLOGY REGENERATIVE MEDICINE © Terumo Corporation Dec. 12, 2016 2/8
Slide 4: Global Market Leader Position
GLOBAL MARKET LEADER POSITION Growth Opportunities for Three Business Segments Blood Centers Therapeutic Systems Cell Processing Delivering higher economic Advancing blood therapies to Enabling cellular therapies and clinical value with strategic bring more treatment options that may fundamentally s
Slide 5: Blood Centers Growth
Blood Centers Leverage Our Market Leadership Delivering higher economic and clinical value with strategic supply chain solutions Mid-Single-Digit Growth Apheresis collections #1 Informatics/software for TGBM Worldwide Sales FY 2016 to FY 2021 blood center management Whole blood automation (WBA
Slide 6: Therapeutic Systems: Advance Therapeutic Apheresis
Therapeutic Systems Advance Therapeutic Apheresis Advancing blood therapies to bring more treatment options to patients High-Single-Digit Created and set the industry standard for Growth therapeutic apheresis devices TGBM Worldwide Sales FY 2016 to FY 2021 #1 Therapeutic plasma exchange Cell col
Slide 7: Cell Processing Growth
Cell Processing Unlocking the Potential of Cells Enabling cellular therapies that may fundamentally improve outcomes Double Digit Creating the market for the first automated system designed to grow adherent and Growth TGBM Worldwide Sales suspension cells in a closed environment FY 2016 to FY 2021
Slide 8: Global Innovation and Development
Global Innovation and Development 24/7 for Maximum Internal Efficiency; Combined with 30 Global Partners Fujinomiya Larne Filters Engineering Fluids Engineering Plastics Engineering Process Engineering Long Thanh Process Engineering Leuven/Zaventem Lakewood Hardware Engineering Hardware Engineering
Slide 9: Every Second of Every Day
EVERY SECOND OF EVERY DAY We Are Saving Lives Here CONTRIBUTING TO SOCIETY THROUGH HEALTHCARE © Terumo Corporation Dec. 12, 2016 8/8
Slide 10: © Terumo Corporation
“TERUMO © Terumo Corporation
Slide 11: Disclaimer
Disclaimer The information that Terumo discloses and the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that